Custom Protein Production for Antibody Development

Custom protein production for antibody development provides a target-specific recombinant antigen when a catalog protein does not match the required sequence, construct, expression system, tag, purity or formulation. Beta LifeScience supports catalog, semi-custom and fully custom protein production, with the option to coordinate antigen preparation with monoclonal or polyclonal antibody development. Researchers can request a full-length protein, selected domain, mutant, isoform or specialized membrane-associated antigen according to the intended antibody application.

Request a Custom Protein Quote | Discuss Your Antigen Design

custom protein production

How Can a Custom Protein Support Antibody Development?

Depending on the project, a custom recombinant protein can support:

  • Animal immunization
  • Antibody screening
  • Specificity testing
  • Antigen-affinity purification
  • ELISA assay development
  • Western blot controls
  • Binding studies
  • Functional validation

The protein can be customized according to the target species, sequence, construct boundaries, expression host, purification tag, purity, endotoxin level, buffer, formulation and required quantity. Direct answer: The best custom antigen is a stable and sufficiently pure protein that presents the required target epitope in a format relevant to the final antibody application.

Catalog, Semi-Custom or Fully Custom Protein?

A completely new production workflow may not be required when an existing recombinant protein already meets the project specifications. Researchers should compare available purchasing routes before requesting development.


Production option

Best suited for

Starting point

Customization

Action

Catalog protein

Standard targets and established constructs

Available product

Existing specifications

Browse Recombinant Proteins

Semi-custom protein

Existing protein requiring a different tag, buffer, endotoxin level or packaging format

Established production platform

Selected modifications

Explore Semi-Custom Production

Fully custom protein

Novel sequence, mutant, isoform, uncommon species or specialized construct

Customer sequence or target information

Extensive customization

Request Custom Production

Integrated protein and antibody project

Researchers requiring both antigen preparation and antibody generation

Target and application requirements

Coordinated protein and antibody services

Start an Antibody Project


Choose a catalog protein when its sequence, species, host, tag and formulation already fit the study. Semi-custom production is suitable when an established protein needs selected modifications. Fully custom production provides greater control over novel or application-specific antigens.

Catalog, Semi-Custom or Fully Custom Protein

Why Choose Beta LifeScience?

The available services support researchers who require more flexibility than a standard catalog product can provide.

Multiple protein-expression platforms

Available production platforms include bacterial, yeast, insect and mammalian expression systems. The host can be selected according to the target’s folding, post-translational modification, solubility and scale requirements.

Catalog, semi-custom and fully custom routes

Researchers can begin with an existing recombinant protein, request selected modifications through semi-custom production or submit a new construct for fully custom expression.

Integrated protein and antibody production

Beta LifeScience can coordinate recombinant antigen preparation with monoclonal or polyclonal antibody development. This creates continuity between antigen design, protein production, immunization and project-specific screening.

Conventional and membrane-associated targets

Soluble proteins, extracellular domains, functional domains and other conventional constructs can be evaluated. A dedicated transmembrane protein expression service is also available for complex membrane-associated targets.

Customizable protein specifications

Project specifications may include:

  • Construct boundaries
  • Expression system
  • Tag type and position
  • Tag-removal strategy
  • Purity target
  • Endotoxin requirement
  • Buffer and concentration
  • Liquid or lyophilized formulation
  • Packaging format
  • Production quantity

Project-specific quality control

Quality-control methods and acceptance criteria can be defined during quotation. Researchers should confirm which purity, identity, endotoxin or functional analyses will be included before production starts.

Technical feasibility review

The target sequence and project requirements are reviewed before the final scope, confirmed timeline and quotation are prepared. This helps match the production strategy to the intended antibody application.

Scale-up and repeat production

Protein expression and purification can support small-scale research and larger production requirements. Buyers planning long-term studies can discuss scale-up, repeat batches, lot requirements and packaging during project evaluation.

Submit Your Target for Feasibility Review

Select the Right Antigen Format


Antigen format

Suitable antibody goal

Main selection consideration

Full-length protein

Broad epitope coverage

Folding, size and solubility

Extracellular domain

Cell-surface receptor antibodies

Native-like domain structure

Functional domain

Antibodies against a defined region

Stable construct boundaries

Truncated protein

Soluble production of a challenging target

Retention of the required epitope

Mutant or isoform

Variant-specific antibodies

Unique sequence and suitable controls

Fusion protein

Improved expression or purification

Potential immune response to the tag

Membrane-protein format

Conformational membrane-target recognition

Epitope presentation and stabilization


Full-length protein or selected domain?

A full-length protein presents multiple potential epitopes and may be suitable when broad target recognition is required. A selected domain can focus the immune response on an extracellular, functional or application-relevant region. For large, multidomain or poorly soluble targets, a carefully selected domain may provide a more practical antigen. Construct boundaries should preserve the intended epitope while supporting protein stability.

Mutants and isoforms

Custom production can support antibodies against disease-associated mutations, splice isoforms or species-specific sequences. Include related wild-type or alternative-isoform proteins in the screening plan when target discrimination is important.

Membrane-associated targets

Membrane proteins may require an extracellular domain, cell-based antigen or specialized presentation format. The preferred approach depends on whether the antibody should recognize a linear sequence, folded domain or native membrane-associated conformation.

Antigen Format

Choose the Appropriate Expression System

Expression-system selection influences folding, post-translational modifications, production yield and scalability.


Expression system

Key production advantage

Commonly considered for

E. coli

Efficient expression and straightforward scale-up

Non-glycosylated proteins, intracellular targets and soluble domains

Yeast

Scalable eukaryotic expression

Secreted proteins and selected eukaryotic antigens

Insect cells

Supports complex folding and several modifications

Multidomain proteins and complex antigens

HEK293 cells

Mammalian folding and processing

Secreted proteins, receptors and extracellular domains

CHO cells

Mammalian expression with scale-up potential

Complex glycoproteins and larger production requirements


An E. coli platform can suit proteins that do not require complex mammalian processing. Mammalian expression is often selected when folding, disulfide bonding or glycosylation contributes to the required epitope. Yeast and insect-cell systems provide additional production routes for selected eukaryotic proteins. The final recommendation should be based on sequence analysis, application and production requirements.

Researchers can review the protein expression host-selection guide or request a technical recommendation.

Appropriate Expression System

Select a Suitable Purification Tag

Tags can support protein expression, purification, detection and immobilization.


Tag option

Potential use

His tag

Affinity purification and routine detection

GST tag

Purification and possible solubility support

Fc tag

Dimerization and protein A/G purification

AviTag

Site-specific biotinylation and controlled immobilization

FLAG or HA

Established detection workflows

Tag-free protein

Reducing tag-related responses during immunization

Depending on the project, the tag can be removed before immunization or different tags can be used during immunization and screening. Review the protein tag-selection guide when comparing tag types, positions and cleavage options.

Define Purity, Endotoxin and Formulation Requirements

Specifications should be selected according to how the antigen will be used.

Protein purity

Purity requirements may differ between immunization, screening, affinity purification and functional testing. The requested purity target and analytical method should be included in the project proposal.

Endotoxin level

Endotoxin control can be important for proteins produced in bacterial systems and used in sensitive cell-based or in vivo applications. Request a defined endotoxin specification and testing report when the downstream workflow requires them.

Existing targets may also be available through the ultra-low endotoxin recombinant protein collection.

Buffer and formulation

The formulation should remain compatible with immunization, conjugation, immobilization, screening or storage requirements. Available options can be discussed for:

  • Buffer composition
  • Protein concentration
  • Stabilizing additives
  • Liquid or lyophilized format
  • Small aliquots
  • Bulk packaging

Share any buffer restrictions during feasibility review, especially when the protein will be used with a particular adjuvant, conjugation method or assay surface.

Endotoxin and Formulation Requirements

Match the Antigen to the Antibody Application

The final antibody application should influence construct and antigen selection.


Final application

Antigen-selection priority

ELISA

Purified, stable protein with accessible epitopes

Western blot

Recognition of linear or denatured epitopes

Flow cytometry

Native extracellular or membrane-associated presentation

Immunohistochemistry

Epitopes retained following fixation and processing

Immunofluorescence

Relevant cellular structure and fixation compatibility

Immunoprecipitation

Accessible epitopes in folded proteins or complexes

Neutralization

Native structure and functionally relevant epitopes

Affinity purification

Stable immobilization with the target epitope available


A protein format suitable for Western blot antibody development may not be ideal for flow cytometry or neutralization. Sharing the intended application during feasibility review supports a more relevant construct and screening plan.

Antigen to the Antibody Application

Custom Protein Production Workflow

The Beta LifeScience custom production workflow begins with a technical review and progresses through expression, purification, quality control and delivery.

1. Submit the target

Provide the protein name, species, accession number or sequence. Include the required construct and intended antibody application where available.

2. Complete a feasibility review

The technical team evaluates construct design, expression host, purification tag, expected quantity and quality requirements.

3. Review the proposal and quotation

The project proposal defines the agreed scope, specifications, potential deliverables, quality-control methods, pricing and confirmed timeline.

4. Begin protein expression and purification

The approved construct is prepared for the selected host, expressed and purified according to the agreed workflow.

5. Complete quality-control evaluation

The protein is evaluated using the analytical methods included in the quotation. Results are documented according to the agreed project deliverables.

6. Receive the protein or continue antibody development

The purified protein can be delivered for the researcher’s own workflow or transferred into an integrated monoclonal or polyclonal antibody-development project.

Custom Protein Production Workflow

Potential Project Deliverables

Exact deliverables depend on the selected protein, production strategy and approved quotation.


Potential deliverable

Purpose

Purified recombinant protein

Immunization, screening, affinity purification or assay development

Certificate of Analysis

Product and batch specifications

Purity analysis

Confirmation of the agreed protein-quality specification

Identity report

Confirmation of the intended protein target

Endotoxin report

Documentation for sensitive downstream applications

Custom formulation

Compatibility with immunization, storage or assay workflows

Packaged aliquots or bulk material

Support for small studies or larger projects

Antibody-development results

Tracking of an integrated protein and antibody project

Project-specific QC results

Documentation of analyses included in the quotation

Potential Project Deliverables

What Determines Pricing and Timeline?

Custom protein production is quoted individually because each target can require a different construct, expression and purification strategy.

Pricing generally depends on:

  • Sequence length and complexity
  • Construct-design requirements
  • Selected expression system
  • Soluble or membrane-associated format
  • Required production yield
  • Purity target
  • Endotoxin specification
  • Tag type and tag removal
  • Buffer and formulation
  • Quality-control requirements
  • Packaging and aliquoting
  • Antibody-development scope

A soluble domain expressed in a microbial system can require a different workflow from a glycosylated mammalian protein or complex membrane-associated antigen. The confirmed timeline is provided after technical feasibility review. It reflects construct preparation, protein expression, purification, quality control and any connected antibody-development stages. Buyers should include their preferred delivery date when requesting a quotation.

Information Required for a Quote

Use this checklist when submitting a project:


Information

Details to provide

Target

Protein name, gene symbol or accession number

Species

Human, mouse, rat, viral or another organism

Sequence

Full sequence or required amino-acid range

Construct

Full-length, domain, extracellular region, mutant or isoform

Application

Immunization, ELISA, Western blot, flow cytometry or another use

Expression host

Preferred host or request a recommendation

Tag

Type, position and removal requirement

Quantity

Required amount and possible repeat-production needs

Purity

Requested purity target

Endotoxin

Required specification, where applicable

Formulation

Buffer, concentration and liquid or lyophilized format

Quality control

Required identity, purity, endotoxin or functional analyses

Packaging

Individual aliquots or bulk packaging

Antibody scope

Protein only, polyclonal antibody or monoclonal antibody project

Timeline

Preferred delivery date or research milestone


If every technical specification has not yet been selected, submit the sequence, intended application and required quantity. A suitable production strategy can be recommended following review.

Submit a Project Evaluation | Contact Technical Support

Start Your Custom Protein Project

Beta LifeScience offers catalog, semi-custom and fully custom protein-production routes for antibody generation, screening and validation. Researchers can request a project-specific construct, expression host, tag, purification strategy, purity level, endotoxin specification, formulation and production scale.

Projects requiring antigen preparation and antibody generation can combine custom protein expression with monoclonal or polyclonal antibody production.

Request a Custom Protein Quote | Start an Antibody Project | Discuss Your Target

FAQs

What is the best protein antigen for antibody development?

The best antigen presents the required target epitope in a stable and relevant format. Depending on the intended application, this may be a full-length protein, extracellular domain, functional domain, mutant, isoform or specialized membrane-protein format.

Which expression system should be used for an antibody antigen?

The expression system should match the protein’s folding and modification requirements. E. coli can suit many non-glycosylated proteins, while mammalian expression may be preferred for complex extracellular proteins and glycoproteins.

Should a purification tag be removed before immunization?

Tag removal can help limit tag-specific immune responses. Another strategy is to use different tags during immunization and antibody screening. The appropriate choice depends on protein stability and the development plan.

Can custom protein production include antibody development?

Yes. Custom protein expression can be coordinated with monoclonal or polyclonal antibody production. The exact antigen, immunization, screening and final deliverables should be defined in the project quotation.

How much does custom protein production cost?

Pricing depends on sequence complexity, construct design, expression system, required yield, purity, endotoxin specification, tag removal, formulation, quality control and antibody-development scope.

How long does custom protein production take?

The timeline depends on the target, construct, expression platform, purification requirements and quality-control scope. A confirmed timeline is provided after feasibility review.

What deliverables are included?

Deliverables are defined in the approved quotation. They may include purified recombinant protein, a CoA, purity analysis, identity results, endotoxin documentation, custom formulation and project-specific quality-control reports.